We therefore hypothesized that inhibition of MLK3 with the novel, brain-penetrant MLK3 inhibitor URMC099 [17], [26] might reduce migration of breast cancer cells in vitro and prevent formation of brain metastases in vivo. This evidence concerns the gene MAP3K11 and breast cancer.